EUVIMEDEUVIMED entdecken
Crossref

Mechanism of Xing 9 ling tablet candy for alcoholic liver disease based on network pharmacology

Xiaomei Zhao, Qiong Qu, Ying Zhang, Peiyuan Zhao, Xinbo Zhang, Yingying Tang, Xuan Lei, Xuan Wei, Xiao Song

Analytical Biochemistry · 2024

DOI: 10.1016/j.ab.2024.115534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Biochemistry, 2024. Verfasst von Xiaomei Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic, Network Pharmacology, Drugs, Chinese Herbal, Molecular Docking Simulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Education Department of Shaanxi Provincial government, Shaanxi Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xing 9 Ling tablet candy (X9LTC) effectively treats alcoholic liver disease (ALD), but its potential mechanism and molecular targets remain unstudied. We aimed to address this gap using network pharmacology. Furthermore, high-performance liquid chromatography (HPLC) and database analysis revealed a total of 35 active ingredients and 311 corresponding potential targets of X9LTC. Protein interaction analysis revealed PTGS2, JUN, and FOS as its core targets. Enrichment analysis indicated that chemical carcinogenesis-receptor activation, IL-17 and TNF signaling pathway were enriched by multiple core targets, which might be the main pathway of action. Further molecular docking validation showed that the core targets had good binding activities with the identified compounds. Animal experiments showed that X9LTC could reduce the high expression of ALT, AST and TG in the serum of ALD mice, alleviate the lesions in liver tissues, and reverse the high expression of PTGS2, JUN, and FOS proteins in the liver tissues. In this study, we established a method for the determination of X9LTC content for the first time, and predicted its active ingredient and mechanism of action in treating ALD, providing theoretical basis for further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Diseases, AlcoholicNetwork PharmacologyDrugs, Chinese HerbalMolecular Docking SimulationAnimalsMiceMaleTabletsCyclooxygenase 2Mice, Inbred C57BLChromatography, High Pressure LiquidLiver

Stichwörter der Autor:innen

Alcoholic liver diseaseGEO databaseHPLCMolecular dockingNetwork pharmacologyXing 9 ling tablet candy

Substanzen

Drugs, Chinese HerbalTabletsCyclooxygenase 2

Autor:innen und Institutionen

  • Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China.
  • Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China; Engineering Research Center for Pharmaceutics of Chinese Materia Medica and New Drug Development, Ministry of Education, Beijing, 100029, China.…

Förderung

  • Education Department of Shaanxi Provincial government
  • Shaanxi Administration of Traditional Chinese Medicine

Zitieren

APA

Zhao, X., Qu, Q., Zhang, Y., Zhao, P., Zhang, X., Tang, Y., Lei, X., Wei, X., & Song, X. (2024). Mechanism of Xing 9 ling tablet candy for alcoholic liver disease based on network pharmacology. Analytical Biochemistry. https://doi.org/10.1016/j.ab.2024.115534

Vancouver

Zhao X, Qu Q, Zhang Y, Zhao P, Zhang X, Tang Y, et al. Mechanism of Xing 9 ling tablet candy for alcoholic liver disease based on network pharmacology. Analytical Biochemistry. 2024. doi:10.1016/j.ab.2024.115534

BibTeX
@article{Zhao2024,
  author = {Zhao, Xiaomei and Qu, Qiong and Zhang, Ying and Zhao, Peiyuan and Zhang, Xinbo and Tang, Yingying and Lei, Xuan and Wei, Xuan and Song, Xiao},
  title = {Mechanism of Xing 9 ling tablet candy for alcoholic liver disease based on network pharmacology},
  journal = {Analytical Biochemistry},
  year = {2024},
  doi = {10.1016/j.ab.2024.115534}
}
Kostenlos starten →